Literature DB >> 3843352

Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons.

J W Greiner, J Schlom, S Pestka, J A Langer, P Giacomini, M Kusama, S Ferrone, P B Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3843352     DOI： 10.1016/0163-7258(85)90023-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  6 in total

1.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.

Authors:  Dong-chul Kang; Rahul V Gopalkrishnan; Qingping Wu; Eckhard Jankowsky; Anna Marie Pyle; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 2.  Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.

Authors:  Paola M Barral; Devanand Sarkar; Zao-zhong Su; Glen N Barber; Rob DeSalle; Vincent R Racaniello; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2009-07-15       Impact factor: 12.310

3.  Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons.

Authors:  G M Graham; L Guarini; T A Moulton; S Datta; S Ferrone; P Giacomini; R S Kerbel; P B Fisher
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferons.

Authors:  J A Leon; M C Gutierrez; H Jiang; A Estabrook; S Waxman; P B Fisher
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  In vitro differentiation and antigenic changes in human melanoma cell lines.

Authors:  L Guarini; M Temponi; G M Edwalds; J R Vita; P B Fisher; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.

Authors:  F Guadagni; J Schlom; S Pothen; S Pestka; J W Greiner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.